Fast-food chain McDonald’s, an economic indicator because of its mammoth global presence, posted its worst earnings report since 2020.
Our daily email brings you smart and engaging news and analysis on the biggest stories in business and finance. For free.
Jim Chanos admits he completely missed the point about sports gambling in America. Nobody cares how much they lose.
Many people are using buy now, pay later (BNPL) options to circumvent more rigid aspects of credit cards, The Wall Street Journal reported.
During the pandemic, consumers splurged on new cars, computers, and furniture, but the post-covid economy has seen a rise in spending on experiences,…
Novo Nordisk, maker of weight-loss drug Wegovy, struck a deal with online telehealth storefronts that sold cheap knockoffs during shortages.
Microsoft’s latest patent may keep its data centers cool and its energy even cooler.
Pfizer’s stock slumped its lowest level in more than 10 years. The world’s moved on from the pandemic, and nobody loves you when you’re down.
Safety regulators said the company’s famed Autopilot driving system had insufficient safeguards to avoid accidents.
Reducing beverage-wait times is part of Starbucks CEO Brian Niccol’s turnaround plan, which includes tech updates focused on efficiency.
The tech could prevent the phantom braking problem which Tesla vehicles are notorious for.
Funding for startups developing small modular nuclear power plants looks like it’s beginning to dry up.
Apple plans to incentivize artists to use Dolby Atmos spatial-sound technology in their recordings by giving them more platform weight.
To prepare for a slowdown of global trade, US retailers spent months building a massive inventory to prevent empty shelves.
Hertz’s recent track record leaves much to be desired: the rental-car company lost nearly $2.9 billion last year.
Investor worries about a fresh batch of US tariffs have dragged LVMH shares in Paris down 23.6% so far this year.
The company plans to seek regulatory approval for the revolutionary weight loss treatment by the end of the year.